The Johnson & Johnson Vaccine Pause Explained

As the general midterm elections begin, we take a look at where things stand. A new Times/Siena poll suggests that Democrats have a real shot at winning control of both chambers of Congress. But serious obstacles stand in their way, including a financial disadvantage.The New York ...  Show more

For the past few months, you’ve probably been hearing about the turbulence in the bond market.Today, Ben Casselman, the chief economics correspondent for The New York Times, explains what has been happening, and why it matters.Guest: Ben Casselman, the chief economics corresponde ...  Show more

After 6 people in nearly 7 million Johnson & Johnson vaccine recipients developed a rare type of blood clot, the FDA and CDC have recommended a pause on administering that vaccine in the United States. CNBC’s Meg Tirrell digests the news and what it means for the rest of the J&J ...  Show more

American health regulators have paused the use of the Johnson & Johnson coronavirus vaccine, following reports of rare blood clotting in six recipients. Like the AstraZeneca vaccine, Johnson & Johnson is what's known as a viral vector vaccine - where another virus is used like a ...  Show more

CNN’s Chief Medical Correspondent Dr. Sanjay Gupta walks through what we currently know about the CDC and FDA's decision to pause the use of Johnson & Johnson's Covid-19 vaccine, what this means for people who recently received a J&J shot, and why he isn’t panicking. To learn mor ...  Show more

UPDATE 4/13/21: Since this episode published, there has been some evidence linking the Johnson & Johnson coronavirus vaccine to rare blood clots. As of April 13, there were six cases in the U.S. out of more than 6.8 million doses, and one person had died. The CDC and FDA have rec ...  Show more